Dataset from A Phase III International, Randomized, Double-blind, Double-dummy Study to Evaluate the Efficacy and Safety of 300 mg or 600 mg of Intravenous Zanamivir Twice Daily Compared to 75 mg of Oral Oseltamivir Twice Daily in the Treatment of Hospitalized Adults and Adolescents With Influenza

The purpose of this study is to test the safety and efficacy of zanamivir given intravenously and how well it works at two different doses in hospitalized adolescents and adults with flu. Zanamivir will be compared with oseltamivir, which is used for treating flu.

本研究旨在考察静脉输注扎那米韦（zanamivir）的安全性与有效性，同时评估两种不同剂量的扎那米韦在住院流感青少年及成人患者中的临床疗效，并将其与临床常用流感治疗药物奥司他韦（oseltamivir）进行对照。